Full-Time

VP – Operations

Confirmed live in the last 24 hours

Medable

Medable

201-500 employees

Digital platform for conducting clinical trials

No salary listed

Senior, Expert

Bengaluru, Karnataka, India

Category
Generalist Operations
Operations & Logistics
Required Skills
Risk Management
Requirements
  • 15+ years of experience in operations, or general management roles, preferably within the healthcare, technology, or clinical research sectors, or a combination of education and experience.
  • Demonstrated experience leading global capability centers or international teams.
  • Proven success in operational excellence, talent leadership, and financial management.
  • Strong understanding of India’s regulatory landscape, employment practices, and industry dynamics.
  • Strategic thinking with a global mindset.
  • Operational discipline and financial acumen.
  • Inspirational leadership and team building.
  • Executive presence with strong communication skills.
  • Change management and growth orientation.
  • Bachelor’s degree required
Responsibilities
  • Develop and execute the India strategy in alignment with Medable’s global vision and business objectives.
  • Identify and drive growth opportunities within the GCC to enhance its strategic value and operational impact.
  • Serve as a key voice in shaping global strategies with localized expertise and insights.
  • Oversee end-to-end service delivery across all functional areas based in India.
  • Ensure the India team meets or exceeds expectations for quality, productivity, compliance, and innovation.
  • Drive adoption of best practices and continuous improvement across all operational processes.
  • Lead efforts to attract, retain, and develop top-tier talent in India.
  • Promote a high-performance culture anchored in Medable’s mission and values.
  • Champion employee engagement through inclusive programs, leadership development, and career growth opportunities.
  • Own and manage the GCC budget, including cost controls, financial forecasting, and resource allocation.
  • Ensure operational efficiency and continuous improvement to maximize ROI and profitability.
  • Act as the primary liaison between Medable India and global leadership teams.
  • Foster strong partnerships across departments to enable seamless global operations.
  • Communicate India’s contributions and needs effectively to Medable’s executive team.
  • Ensure that all operations within the GCC comply with local laws and global regulatory standards.
  • Build and maintain a robust risk management framework to identify and address operational challenges.
  • Lead internal compliance audits and ensure alignment with Medable’s quality and security protocols.
  • Represent Medable India in industry forums, government panels, and regulatory discussions.
  • Build strategic partnerships with Indian and global stakeholders to strengthen Medable’s market presence.
  • Position the India GCC as a leader in decentralized clinical trials and eCOA (electronic Clinical Outcomes Assessment).
  • Drive initiatives to make Medable a recognized employer of choice in the Indian healthcare tech space.
  • Develop academic and institutional partnerships to build a future-ready talent pipeline.
  • Align India operations with Medable’s global ESG goals.
  • Design and implement CSR programs focused on digital health equity, clinical research education, and community engagement.
Desired Qualifications
  • Master’s degree (MBA or equivalent) preferred.

Medable offers a digital platform that streamlines the clinical trial process for healthcare organizations, including pharmaceutical companies. Its tools facilitate participant onboarding, data collection, study notifications, and real-time reporting, ensuring high-quality data for drug validation. Medable distinguishes itself with a user-friendly design, scalability, and a strong decentralized clinical trial network. The company's goal is to improve the efficiency of clinical trials and enhance healthcare outcomes.

Company Size

201-500

Company Stage

Series D

Total Funding

$506.2M

Headquarters

Palo Alto, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Integration with Google Cloud enhances scalability and global accessibility.
  • Generative AI reduces trial startup time, improving efficiency and patient outcomes.
  • CNIL approval expands opportunities for digital trials across the European Union.

What critics are saying

  • AI-driven SaaS competition could threaten Medable's market share.
  • Dependency on Google Cloud poses operational risks if disruptions occur.
  • Rapid AI adoption may lead to data privacy and security concerns.

What makes Medable unique

  • Medable offers a unified platform for decentralized clinical trials globally.
  • The platform supports 60+ countries and 120 languages, enhancing global reach.
  • Medable's no-code platform empowers non-technical users to design complex trials.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health & wellness

401k

Remote first

Career development

Military support

Time away

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

2%
HR Tech Wire
Mar 4th, 2025
Medable Achieves Landmark CNIL Approval, Expanding Access for Digital Clinical Trials Across the European Union

Medable partnered closely with Servier - one of the largest pharmaceutical sponsors in France - over six months to obtain CNIL approval.

PYMNTS
Dec 12th, 2024
Ai Opens Gold Rush In Niche Business Software Markets

Silicon Valley investors are seeing a wave of opportunities in specialized software for laundromats, chiropractors and other previously overlooked industries as artificial intelligence improves profit potential. The shift comes as AI technology allows software companies to expand from basic business management tools into handling sales, marketing and customer service tasks that were once too complex to automate, potentially increasing revenue per customer tenfold while slashing acquisition costs, according to new research from venture capital firm Andreessen Horowitz. “In vertical SaaS, AI is making previously unprofitable markets viable by increasing customer value and driving down costs,” VisionX founder and CEO Antwyne DeLonde told PYMNTS. “With AI automating complex tasks and delivering personalized solutions, software companies can now serve smaller, niche markets that were once financially out of reach.”

BioPharmaTrend
Nov 14th, 2024
Medable Adds Generative AI to Simplify and Speed Up Clinical Trials

Medable Inc. has introduced generative AI capabilities to its Medable Studio platform to streamline and accelerate digital and decentralized clinical trial workflows.

Outsourcing-Pharma
Nov 13th, 2024
Medable and Google Cloud partner to deliver digital clinical trials technology

Medable's platform will be seamlessly integrated with Google Cloud Marketplace, which will enable users to access Medable's recently launched Studio, a software as a service (SaaS) solution designed to provide pharmaceutical companies control and transparency in clinical trial design, execution, and data management.

Hit Consultant
Nov 12th, 2024
Medable Unveils Generative Ai To Accelerate Clinical Trial Startup

What You Should Know:– Medable Inc., a leader in clinical development technology, has announced Medable AI, a suite of generative AI capabilities designed to revolutionize the clinical trial startup process. Medable AI empowers sponsors and clinical research organizations (CROs) to build digital and decentralized trials faster, with greater efficiency and control.– The launch of Medable AI is part of a broader AI strategy for Medable, with plans to expand AI capabilities across its platform in the future. This reflects the company’s commitment to leveraging cutting-edge technology to accelerate clinical development and improve patient outcomes.Accelerating Time to First Patient In (FPI)Medable AI, integrated into the Medable Studio platform, automates time-consuming manual tasks that traditionally slow down clinical trial startup. By streamlining processes and eliminating repetitive work, Medable AI significantly reduces the time to First Patient In (FPI).For example, building multiple outcomes assessments for a study, a process that typically takes days, can now be completed in just 30 minutes with Medable AI, according to early metrics. This accelerated timeline represents a major breakthrough for the industry, moving towards the ambitious goal of one-day study startup.Enhanced Efficiency and ControlMedable AI offers a range of capabilities to enhance the trial build process:Automated eCOA Creation: Automatically converts existing outcomes assessments into fully digital eCOAs in seconds.Automatically converts existing outcomes assessments into fully digital eCOAs in seconds. Simplified Editing: Provides a user-friendly, ChatGPT-like interface for easy editing of assessments.Provides a user-friendly, ChatGPT-like interface for easy editing of assessments